Moderna Inc Cash Flow Quality Index
Moderna Inc cash flow quality index. Moderna Inc (MRNA) has a Cash Flow Quality Index of -120.46x as of September 2024. Operating cash flow of $-1.57 Billion is below net income of $13.00 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Moderna Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Moderna Inc (2021–2022)
Cash flow quality index of Moderna Inc from 2021 to 2022. Historical Cash Flow Quality Index for Moderna Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. See MRNA equity financing ratio to measure how much of total assets are equity-financed.
Moderna Inc Cash Flow Quality Index by Year (2021–2022)
Moderna Inc cash flow quality index by year from 2021 to 2022. Year-by-year earnings quality comparison for Moderna Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Moderna Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.60x | $4.98 Billion | $8.36 Billion | ▼ -46.6% |
| 2021 | 1.12x | $13.62 Billion | $12.20 Billion | — |